Provided by Tiger Fintech (Singapore) Pte. Ltd.

Moleculin Biotech

0.9799
-0.0136-1.37%
Post-market: 0.9383-0.0416-4.25%19:43 EDT
Volume:256.05K
Turnover:248.59K
Market Cap:13.72M
PE:-0.16
High:1.00
Open:1.00
Low:0.9225
Close:0.9935
Loading ...

Moleculin to Report Full Year 2024 Financial Results on March 21, 2025 and Host Conference Call and Webcast

GlobeNewswire
·
19 Mar

Moleculin Biotech Inc expected to post a loss of $1.28 a share - Earnings Preview

Reuters
·
19 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
14 Mar

Moleculin to Present at the 37th Annual ROTH Conference

PR Newswire
·
10 Mar

BRIEF-Moleculin Biotech Inc Announces Additional Annamycin Patent Allowances To Enhance Global Exclusivity

Reuters
·
06 Mar

Moleculin Biotech Inc: New Patents Will Extend Coverage to Major Markets Outside U.S.

THOMSON REUTERS
·
06 Mar

Moleculin Biotech Inc: Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity

THOMSON REUTERS
·
06 Mar

Moleculin Biotech to be granted new patents for Annamycin

TIPRANKS
·
06 Mar

Moleculin Announces Additional Annamycin Patent Allowances to Enhance Global Exclusivity

PR Newswire
·
06 Mar

Moleculin Biotech Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
03 Mar

Moleculin Abstract Accepted for Poster Presentation at the Acute Leukemias XIX (ISALXIX) International Symposium

PR Newswire
·
03 Mar

Buy Rating for Moleculin Biotech: Accelerated Annamycin Development and Strategic Advancements

TIPRANKS
·
03 Mar

Moleculin Biotech target adjusted to $8 from $45 at H.C. Wainwright

TIPRANKS
·
03 Mar

Moleculin Biotech Pares Gains After Securities-Purchase Agreement

Dow Jones
·
26 Feb

Moleculin Biotech Prices $3.5 Million Direct Offering; Shares Rise

MT Newswires Live
·
26 Feb

Moleculin Biotech announces pricing of $3.5M registered direct offering

TIPRANKS
·
26 Feb

Moleculin Announces Pricing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced at the Market Under Nasdaq Rules

THOMSON REUTERS
·
26 Feb

Moleculin Announces Pricing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At The Market Under Nasdaq Rules

PR Newswire
·
26 Feb

US Futures Modestly Lower as Investors Await Retail Sales, Industrial Production Data

MT Newswires Live
·
14 Feb

BUZZ-Moleculin Biotech soars as FDA approves cancer drug trial

Reuters
·
14 Feb